We take your privacy very seriously, please consent to the use of all cookies when visiting our website. for more information on the processing of personal data, please refer to the Privacy Policy.

Menu
Find a Doctor
What can we help you find?
EN
Appointment Service download.svg a0_icon_02_01.svg
  • Key Clinical Departments
  • Elite Physicians
  • Centers of Excellence
  • Specialized Medical Services
  • Start Your Care
  • Fee-Based Services
  • About Pinnacle
  • MCCN
Xu-Xun.png

Xu Xun

  • Chief Physician of Urology
  • Professor
  • Chief Physician

Urology 

Languages Spoken： Mandarin 、

Vice Chairperson of the Urology Branch of the Guangdong Medical Association; Member of the Prostate Cancer Group of the Chinese Urological Association

Book Now
IMC-QR.jpg
Back to Doctors
Doctor Details
  • Specialties
  • Academic Experience & Positions
Book Now
IMC-QR.jpg
Back to Doctors
Book Now
IMC-QR.jpg

Be Good at

Prof. Xu has in-depth research on urinary calculi, male reproductive system tumors, benign prostatic hyperplasia (BPH), and urinary tract infections (UTIs). Proficient in urological minimally invasive surgery, having independently completed nearly 10,000 cases of various minimally invasive procedures.

  • Academic Achievements

    • Supervised 36 master's and doctoral graduates.
    • Published 13 SCI-indexed papers as first author or corresponding author, with the highest impact factor of 11.492, and 22 papers in Chinese core medical journals.
    • Led 8 provincial and municipal research projects.
    • Awarded the Third Prize of Guangdong Provincial Science and Technology Award in 2008 (first completer).
    • Participated as a principal investigator in 10 international multicenter clinical studies.
    • Contributed to the compilation of the "Guidelines for Urinary Management and Clinical Rehabilitation of Patients with Spinal Cord Injury," "Guidelines for Diagnosis and Treatment of Overactive Bladder," "Guidelines for Diagnosis and Treatment of Benign Prostatic Hyperplasia," and "Chinese Expert Consensus on Botulinum Toxin for Lower Urinary Tract Dysfunction."
    • Serves as an editorial board member of the "Chinese Journal of Urology" and Deputy Editor-in-Chief of the "Chinese Journal of Functional Urology."
    • Since 2016, clinical papers have been cited annually in the European Association of Urology (EAU) Guidelines on the surgical management of benign prostatic hyperplasia.

  • Social Position

    • Former Member of the Chinese Society of Integrated Traditional Chinese and Western Medicine Urology
    • Member of the Stone Group
    • Member of the Infection Group; Member of the Chinese Urinary Stone Alliance; Vice Chairman of the Chinese Society of Maternal and Pediatric Urology; Member of the Stone Group
    • Member of the Laser Group, Guangdong Urology Branch; Standing Committee Member
    • Member of the Stone Group, Guangdong Society of Integrated Traditional Chinese and Western Medicine Urology; Member
    • Member of the Stone Group, Guangdong Urological Physician Branch; Vice Chairman of the Renal Surgery Branch
    • Standing Committee Member of the Prostate Group, Guangdong Association of Genitourinary Reproduction